Announcement

Collapse
No announcement yet.

Sernova Corp

Collapse
X
  • Filter
  • Time
  • Show
Clear All
new posts

    Sernova to employ glucose monitoring system in upcoming clinical trial

    http://aheadoftheherd.com/Newsletter...monitoring.pdf

    Comment


      looks like some on at Echelon doesnt believe in their own write up. Selling in 500 share chunks at a time...

      Comment


        Hi Rick , just wondering if you have heard anything about when the trial might get going. Seems like this thing is stuck in the mud.Very frustrating.

        Comment


          This is how SVA trades when interest and volume fall apart. One seller with a few hundred k can really decrease share price. Been here before many times.
          This is a good time to be picking up more traders to sell into the next news release.
          The fundamentals havnt changed so I continue to hold on to my core position - for now.

          Comment


            Im buying a few down here. Still likely to go lower yet but Im bidding in small portions.

            Comment


              From the March 29th MD&A:

              "Research and Development Outlook for the 2018 Calendar Year Our research and development program for 2018 includes the following:
               Initiate a clinical trial of our Cell Pouch™ in collaboration with JDRF under our recently cleared US IND for patients with hypoglycemia unawareness using human donor islets and a standard of care antirejection drug regimen to further study the safety and efficacy of the device and islets;
               Clinical evaluation of the Cell Pouch™ for insulin-dependent diabetes who have received an islet transplant;
               In coordination with the EU Horizon 2020 HemAcure Consortium. conduct cell production and preclinical studies for treatment of hemophilia A consisting of factor VIII releasing therapeutic cells transplanted within Sernova’s Cell Pouch™;
               Conduct preclinical studies for treatment of hypo-thyroid disease consisting of thyroid hormone releasing tissue transplanted within Sernova’s Cell Pouch™;
               Production of human stem-cell-derived cells for diabetes and in vivo proof of principle assessment of these differentiated human stem cells for their safety and efficacy within Sernova’s Cell Pouch™ for the treatment of insulin-dependent diabetes;
               Assessment of novel microencapsulation technologies within the Cell Pouch™ cells, to further develop and advance Sernova’s therapeutic vision for diabetes of a product consisting of locally immune protected therapeutic cells within the Cell Pouch™; and
               Continue to collaborate with pharmaceutical companies to assess safety and efficacy of our combined technologies in preclinical studies for potential negotiation of a licensing arrangement and commercial development partnership for our hemophilia and diabetes programs."

              Comment


                Now if Philip would just put out news about all of this and publish regular reports thru the year. Sure does sound good though, that's a lot happening.

                rick

                Comment


                  I fear we might see the .20s again before too long if there isnt a serious NR soon. I get that these things take time, but throw us a bone. I am sriously thinking about dumpoing 1/2 my position during the next run. Its been too many years of waiting.

                  Comment


                    Ray said he'd call with an update.

                    rick

                    Comment


                      I look forward to hearing what he has to say. Thanks Rick

                      Comment


                        I feel exactly the same way Ron. Tired, disappointed, disillusioned. But the IRB meets next week, they meet once a month so its not unusual to take this long.

                        They have been busy making sure the investigator isn't being paid by SVA, That SVA's and the investigator's enrollment process meets their strict ethical guidelines.

                        If it's all kosher we might hear about approval in 2-3 weeks. The approval release should kick off a string of releases, clinical site, patients enrolled, patient dosed etc.

                        rick

                        "Research and Development Outlook for the 2018 Calendar Year Our research and development program for 2018 includes the following:

                         Initiate a clinical trial of our Cell Pouch™ in collaboration with JDRF under our recently cleared US IND for patients with hypoglycemia unawareness using human donor islets and a standard of care antirejection drug regimen to further study the safety and efficacy of the device and islets;

                         Clinical evaluation of the Cell Pouch™ for insulin-dependent diabetes who have received an islet transplant;

                         In coordination with the EU Horizon 2020 HemAcure Consortium. conduct cell production and preclinical studies for treatment of hemophilia A consisting of factor VIII releasing therapeutic cells transplanted within Sernova’s Cell Pouch™;

                         Conduct preclinical studies for treatment of hypo-thyroid disease consisting of thyroid hormone releasing tissue transplanted within Sernova’s Cell Pouch™;

                         Production of human stem-cell-derived cells for diabetes and in vivo proof of principle assessment of these differentiated human stem cells for their safety and efficacy within Sernova’s Cell Pouch™ for the treatment of insulin-dependent diabetes;

                         Assessment of novel microencapsulation technologies within the Cell Pouch™ cells, to further develop and advance Sernova’s therapeutic vision for diabetes of a product consisting of locally immune protected therapeutic cells within the Cell Pouch™; and

                         Continue to collaborate with pharmaceutical companies to assess safety and efficacy of our combined technologies in preclinical studies for potential negotiation of a licensing arrangement and commercial development partnership for our hemophilia and diabetes programs."

                        Comment


                          Sernova Corp about to start FDA cell pouch diabetes trials

                          http://aheadoftheherd.com/Newsletter...tes-trials.pdf

                          Comment


                            Remember when Philip was talking about a black out? Take it for what its worth but there hasnt been any insider activity in over 6 months. Perhaps there is something in the works of material that is keeping the insiders from making any moves...

                            Comment


                              Sernova Corp ad

                              https://www.youtube.com/watch?featur...fM&app=desktop

                              Comment


                                Facinating video!
                                Zzzz

                                id rather see them higher some market makers/wash traders. We need some volume.

                                Comment

                                Working...
                                X